TrialNature communications2025

Safety and Immunogenicity of aerosolized adenovirus-vectored COVID-19 vaccine and intramuscular mRNA vaccine bivalent boosters: a randomized open-label clinical trial.

Shipo Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.